Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

First: Roche- CIPLA Antibody Cocktail of Casirivimab and Imdevimab for mild to moderate COVID-19 now available in India

Ruchika Sharma24 May 2021 2:44 PM IST

The antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in...

Glenmark gets USFDA nod for Single-Dose Prefilled Icatibant Injection

Ruchika Sharma24 May 2021 1:21 PM IST

Mumbai: Drugmaker, Glenmark Pharmaceuticals Limited, today announced that the company has received final approval by the United States Food &...

Not the view of company: Serum Institute distances itself from executive's remarks on vaccination drive

Ruchika Sharma24 May 2021 11:00 AM IST

New Delhi: The Serum Institute has disassociated itself from its executive director's statement that the government began the COVID-19 vaccination of...

Zydus Cadila launches breast cancer drug Ujvira

Ruchika Sharma24 May 2021 10:00 AM IST

In a step that can significantly reduce treatment cost by almost 80%, the drug is being offered at Rs. 32495 for a 100 mg vial.

Double dose of COVID vaccines effective against India variant, says English health officials

Ruchika Sharma24 May 2021 9:30 AM IST

London: A double dose of COVID-19 vaccines is almost as effective against the fast-spreading variant of the coronavirus first identified in India as...

MSN Labs unveils Posaconazole for Black Fungus treatment in India

Ruchika Sharma23 May 2021 12:00 PM IST

Hyderabad: MSN Laboratories on Friday announced the launch of Posaconazole, a triazole antifungal agent indicated for treating Black Fungus...

Natco Pharma marketing partner gets USFDA approval for Everolimus tablets

Ruchika Sharma23 May 2021 11:30 AM IST

Hyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company's marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has...

Sun Pharma appoints ex MD of Mahindra and Mahindra Pawan Goenka, Rama Bijapurkar as independent directors

Ruchika Sharma23 May 2021 10:15 AM IST

New Delhi: Drug major Sun Pharma has announced appointment of Pawan Goenka, former MD of Mahindra and Mahindra (M&M), and management consultant...

COVID-19: Natco Pharma begins Molnupiravir capsules Phase III trial in India

Ruchika Sharma23 May 2021 9:45 AM IST

Hyderabad: Drug major, Natco Pharma Limited, has initiated Phase-III clinical trial of Molnupiravir capsules in India. Its first patient was...

Eli Lilly, BDR Pharma ink pact for COVID drug Baricitinib

Ruchika Sharma23 May 2021 9:00 AM IST

New Delhi: Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution...

Serum Institute executive director says Govt widened COVID vaccination drive without considering stock, WHO guidelines

Ruchika Sharma22 May 2021 4:07 PM IST

New Delhi: Amid an acute shortage of Covid-19 vaccines in the country, executive director of Pune-based Serum Institute of India (SII) Suresh Jadhav...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Morepen Labs to get Rs 433 crore from Corinth, promoters

Ruchika Sharma22 May 2021 3:53 PM IST

New Delhi: Morepen Laboratories Limited has approved incoming investment of Rs. 433 crore in the Extra-Ordinary General Meeting (EGM) of the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok